What one share of Hyperfine holds
We are an innovative health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (“AI”)-powered portable ultra-low-field (“ULF”) magnetic resonance (“MR”) brain imaging.
Hyperfine’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.18 |
|---|---|
| Profit | −$0.38 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.30 |
| Cash and investments | $0.44 |
| Debt | $0.13 |
| Book value | $0.37 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $0.19 | −$15.38 | $1.03 | −$15.16 | — | −$40.09 |
| 2021 | $0.41 | −$17.57 | $0.73 | −$13.52 | — | $50.46 |
| 2022 | $0.10 | −$1.04 | $0.01 | −$1.04 | — | $1.76 |
| 2023 | $0.15 | −$0.62 | $0.01 | −$0.60 | — | $1.18 |
| 2024 | $0.18 | −$0.56 | $0.01 | −$0.54 | — | $0.68 |
| 2025 | $0.17 | −$0.43 | $0.01 | −$0.36 | — | $0.50 |
Common questions about Hyperfine
How much does one share of Hyperfine earn?
Over the last 12 months, Hyperfine lost $0.38 for each share on $0.18 of sales.
Does Hyperfine pay a dividend?
Hyperfine didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Hyperfine’s book value per share?
Hyperfine’s book value is $0.37 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Hyperfine have?
Each share of Hyperfine has $0.44 of cash and investments and $0.13 of debt, as of June 30, 2026.
What is Hyperfine’s free cash flow per share?
−$0.30 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Hyperfine bought back shares?
Hyperfine’s share count rose about 5270% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.